Literature DB >> 2349433

A follow-up study of pulmonary function in patients with primary Sjögren's syndrome.

M Linstow1, N J Kriegbaum, V Backer, C Ulrik, P Oxholm.   

Abstract

Twenty-seven patients (25 women, 2 men) with primary Sjögren's syndrome, previously reported to have reduced pulmonary diffusing capacities were reexamined in a 7-year follow-up in order to evaluate longitudinal alterations in pulmonary function. Primary Sjögren's syndrome was diagnosed according to the Copenhagen criteria. The present examination revealed normal and unchanged values for vital capacity, forced expiratory volume in 1 s, maximal expiratory flow at 50% of expired vital capacity (MEF50), and diffusing capacity per liter alveolar volume. Total diffusing capacity (P less than 0.01) and MEF75 (P less than 0.05), were, however, significantly reduced compared with the predicted values, indicating pulmonary involvement primarily affecting the small airways. The longitudinal examination, furthermore, showed increasing values for total diffusing capacity (P less than 0.02), diffusing capacity per liter alveolar volume (P less than 0.001), and MEF75 (P less than 0.02), suggesting an improvement in lung status in the course of time. No correlation was found between MEF75 and diffusing capacities, nor between alterations in pulmonary function and complaints of dyspnoea, tiredness, cough, expectoration, tobacco smoking, or medical treatment with bromhexine, glucocorticosteroids, essential fatty acids, or nonsteroid antiinflammatory drugs.

Entities:  

Mesh:

Year:  1990        PMID: 2349433     DOI: 10.1007/bf02274782

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  17 in total

Review 1.  Pulmonary involvement in the collagen vascular diseases.

Authors:  G W Hunninghake; A S Fauci
Journal:  Am Rev Respir Dis       Date:  1979-03

2.  Circulating IgM rheumatoid factors in patients with primary Sjögren's syndrome.

Authors:  K Müller; R Manthorpe; H Permin; M Høier-Madsen; P Oxholm
Journal:  Scand J Rheumatol Suppl       Date:  1988

3.  Pulmonary involvement in Sjögren's syndrome.

Authors:  F Bariffi; A Pesci; G Bertorelli; P Manganelli; U Ambanelli
Journal:  Respiration       Date:  1984       Impact factor: 3.580

4.  Xerotrachea and interstitial lung disease in primary Sjogren's syndrome.

Authors:  S H Constantopoulos; A A Drosos; P J Maddison; H M Moutsopoulos
Journal:  Respiration       Date:  1984       Impact factor: 3.580

5.  Pulmonary function in patients with primary Sjögren's syndrome.

Authors:  P Oxholm; A Bundgaard; E Birk Madsen; R Manthorpe; F Vejlø Rasmussen
Journal:  Rheumatol Int       Date:  1982       Impact factor: 2.631

6.  Subclinical lung inflammation in primary Sjögren's syndrome. Relationship between bronchoalveolar lavage cellular analysis findings and characteristics of the disease.

Authors:  P Y Hatron; B Wallaert; D Gosset; A B Tonnel; B Gosselin; C Voisin; B Devulder
Journal:  Arthritis Rheum       Date:  1987-11

7.  Pulmonary disorders associated with Sjögren's syndrome.

Authors:  A J Fairfax; P L Haslam; D Pavia; N F Sheahan; J R Bateman; J E Agnew; S W Clarke; M Turner-Warwick
Journal:  Q J Med       Date:  1981

8.  Gallium-67 scanning in Sjögren's syndrome: concise communication.

Authors:  R D Collins; G V Ball; J R Logic
Journal:  J Nucl Med       Date:  1984-03       Impact factor: 10.057

9.  Pulmonary function abnormalities in Sjögren's syndrome and the sicca complex.

Authors:  I Segal; G Fink; I Machtey; V Gura; S A Spitzer
Journal:  Thorax       Date:  1981-04       Impact factor: 9.139

10.  Chronic obstructive airway disease in patients with Sjögren's syndrome.

Authors:  H H Newball; S A Brahim
Journal:  Am Rev Respir Dis       Date:  1977-02
View more
  5 in total

Review 1.  Pulmonary manifestations of Sjögren's syndrome.

Authors:  George Stojan; Alan N Baer; Sonye K Danoff
Journal:  Curr Allergy Asthma Rep       Date:  2013-08       Impact factor: 4.806

2.  An 8-year follow-up study of pulmonary function in patients with rheumatoid arthritis.

Authors:  M Linstow; C S Ulrik; N J Kriegbaum; V Backer; P Oxholm
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

3.  Bronchus-associated lymphoid tissue lymphoma in a patient with primary Sjögren's syndrome.

Authors:  Francesca Ingegnoli; Alba Sciascera; Valentina Galbiati; Vincenzo Corbelli; Enzo D'Ingianna; Flavio Fantini
Journal:  Rheumatol Int       Date:  2008-07-01       Impact factor: 3.580

4.  Eight-year follow-up of airway hyperresponsiveness in patients with primary Sjögren's syndrome.

Authors:  Dora Ludviksdottir; Sigridur Th Valtysdottir; Hans Hedenström; Roger Hällgren; Björn Gudbjörnsson
Journal:  Ups J Med Sci       Date:  2016-11-16       Impact factor: 2.384

Review 5.  Pulmonary Manifestations of Primary Sjögren's Syndrome: Underlying Immunological Mechanisms, Clinical Presentation, and Management.

Authors:  Sarthak Gupta; Marcela A Ferrada; Sarfaraz A Hasni
Journal:  Front Immunol       Date:  2019-06-12       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.